Afraceuticals is excited to announce that we have embarked on a new partnership with Australian-based speciality healthcare ingredient distributor, Pathway International.
As a result of this partnership, our Pelargonium sidoides extract, PELAFORCE™ EMA1170™, will become available throughout Australia and New Zealand for the first time. Before the ingredient becomes commercially available in Australia, Afraceuticals and Pathway will apply for regulatory approval with the Therapeutic Goods Association. Once approved, the ingredient will be available for use in supplements, functional foods, and liquids. PELAFORCE™ will be immediately available to New Zealand brands and formulators for use in dietary supplements.
With Pathway’s illustrious industry track record, combined with their reach into Australia and New Zealand, we have the utmost confidence that the peoples of this region will soon be able to enjoy the benefits of a true African botanical. Based in the highlands of South Africa - close to the source of the root - we ethically and sustainably source, dry and process our product, extracting the highly sought after medicinal botanical powder, PELAFORCE™ EMA1170™. Our Pelargonium sidoides water soluble powder extract is accompanied by a DMF and is manufactured in a GMP Facility according to the European monograph. PELAFORCE™ has proven clinical activity as an antiviral, antibacterial, expectorant, and immune modulator.
For more information about Afraceuticals and PELAFORCE™: www.afraceuticals.com